(2) For the quarter ended September 30, 2020, the adjustment included $0.1 in COGS, $0.1 in SG&A; the net loss adjustment also included $0.2 in other income (expense). For the quarter ended September 30, 2019 the adjustment included $(0.2) in Revenue, $0.7 in COGS, $(1.2) in SG&A; the net loss adjustment also included $0.5 in other income (expense). For the nine months ended September 30, 2020, the adjustment included $0.3 in COGS, $0.4 in SG&A; the net loss adjustment also included $— in other income (expense). For the nine months ended September 30, 2019, the adjustment included $(2.9) in Revenues, $4.0 in COGS, $4.1 in SG&A; and the net loss adjustment also included $1.8 in other income (expense).
(3) For the quarter ended September 30, 2020, the adjustment included $11.9 in SG&A. For the quarter ended September 30, 2019, the adjustment included $1.0 in COGS and $0.4 in SG&A. For the nine months ended September 30, 2020, the adjustment included $0.7 in COGS, $13.8 in SG&A, $0.1 in R&D. For the nine months ended September 30, 2019, the adjustment included $1.7 in COGS, $5.0 in SG&A and $0.3 in R&D.
(4) For the quarter and nine months ended September 30, 2020 the net loss adjustment included $1.1 and $2.2, respectively, in interest and other income (expense), net. For the quarter and nine months ended September 30, 2019 the net loss adjustment included $0.3 in interest and other income (expense), net.
(5) For the nine months ended September 30, 2020 , the adjustment included $10.9 in COGS.
(6) For the quarter and nine months ended September 30, 2020, the adjustment included $48.3 in Impairment of goodwill.
(7) Denominator based on weighted average shares used in the GAAP EPS calculation.
* Tables may not foot due to rounding; amounts calculated based on dollars in thousands.
